|
|
|
December 4, 2007
Evalve Completes Series D Financing
Evalve was incorporated in 1999 to design, develop, manufacture, and market innovative devices to enable percutaneous repair of cardiac valves. The company's initial products are intended to reduce the risks, trauma and costs associated with current open, arrested heart surgical options. The company's present development and clinical efforts are focused on mitral valve repair. Evalve recently completed a $60mn Series D financing.
Read more here.
--------------------------------
Back to News
|
|
| |
